| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 10, 2018 | IQV Iqvia Holdings Inc. | Evanisko Michael J | Director | Sell | 815 | $100.00 | $81,500.00 | -10.0% | |
| May 10, 2018 | EXAS Exact Sciences Corp | Wyzga Michael S | Director | Sell | 7,402 | $51.53 | $381,447.27 | -40.3% | |
| May 10, 2018 | NEO Neogenomics Inc | Ross Steven A | CIO | Sell | 81,999 | $10.78 | $883,949.22 | -94.8% | |
| May 9, 2018 | WST West Pharmaceutical Services Inc | Federici William J | Sr. VP &CFO | Sell | 52,000 | $87.14 | $4,531,280.00 | -21.1% | |
| May 7, 2018 | WAT Waters Corp /de/ | Harrington Michael C | SVP, Global Markets | Sell | 16,078 | $194.67 | $3,129,848.52 | -75.7% | |
| May 7, 2018 | MEDP Medpace Holdings, Inc. | Medpace Limited Partnership | 10% Owner | Sell | 3,000,000 | $35.49 | $106,470,000.00 | -18.3% | |
| May 4, 2018 | OPK Opko Health, Inc. | Fishel Robert Scott | Director | Buy | 5,000 | $3.14 | $15,700.00 | +0.1% | |
| May 4, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 26,000 | $3.14 | $81,540.00 | +0.4% | |
| May 3, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 51,800 | $3.09 | $159,998.00 | +0.4% | |
| May 2, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,330 | $3.15 | $158,629.60 | +0.2% | |
| May 1, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 31,222 | $3.05 | $95,210.44 | +0.3% | |
| May 1, 2018 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 945 | $104.23 | $98,498.50 | -0.7% | |
| Apr 30, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 75,000 | $3.08 | $231,126.00 | +0.3% | |
| Apr 26, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 31,800 | $3.03 | $96,449.00 | +0.2% | |
| Apr 26, 2018 | DHR Danaher Corp /de/ | Hefner Linda P58 | Director | Sell | 18,001 | $101.51 | $1,827,196.70 | -26.3% | |
| Apr 26, 2018 | CDNA Caredx, Inc. | Gagnon Neil | 10% Owner | Buy | 10,136 | $9.42 | $95,481.12 | +1.1% | |
| Apr 25, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 55,372 | $2.99 | $165,341.52 | +0.2% | |
| Apr 25, 2018 | OPK Opko Health, Inc. | Fishel Robert Scott | Director | Buy | 12,500 | $2.97 | $37,125.00 | +0.1% | |
| Apr 24, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 75,000 | $2.97 | $222,641.00 | +0.3% | |
| Apr 23, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 75,000 | $3.04 | $227,655.00 | +0.3% | |
| Apr 23, 2018 | DHR Danaher Corp /de/ | Comas Daniel L | EVP &CFO | Sell | 78,379 | $101.67 | $7,968,734.57 | -14.9% | |
| Apr 20, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 60,000 | $3.12 | $187,490.00 | +0.4% | |
| Apr 20, 2018 | DHR Danaher Corp /de/ | Joyce Thomas Patrick Jr | President And CEO | Sell | 120,354 | $101.17 | $12,176,175.95 | -19.7% | |
| Apr 19, 2018 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $3.17 | $31,700.00 | +0.3% | |
| Apr 18, 2018 | RVTY Revvity, Inc. | Tereau Daniel R69 | Please See Remarks | Sell | 1,156 | $77.00 | $89,012.00 | -14.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.